Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5)

This publication has 14 references indexed in Scilit:

• Interferon for hepatitis A
  The Lancet, 1994
• Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions
  Cancer Chemotherapy and Pharmacology, 1992
• Hepatitis A virus infection among homosexual men.
  BMJ, 1991
• Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.
  Proceedings of the National Academy of Sciences, 1991
• Changing epidemiology and clinical aspects of hepatitis A
  British Medical Bulletin, 1990
• Inhibition of hepatitis A virus replication in vitro by antiviral compounds
  Journal of Medical Virology, 1990
• Variable Expression of Pres1 Antigen in Serum During Chronic Hepatitis B Virus Infection: An Accurate Marker for the Level of Hepatitis B Virus Replication
  Hepatology, 1990
• Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology
  Journal of Virological Methods, 1987
• Effect of Hepatitis A Virus Infection on Cell Metabolism in Vitro
  Experimental Biology and Medicine, 1984
• Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B.
  Gut, 1983